United Therapeutics Corp.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $463.4M | $2.33B | $1.02B |
| FY2017 | $758.4M | $2.88B | $705.1M |
| FY2018 | $593.2M | $3.40B | $669.2M |
| FY2019 | $1.13B | $3.91B | $738.4M |
| FY2020 | $1.22B | $4.62B | $738.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $463.4M | $2.33B | $1.02B |
| FY2017 | $758.4M | $2.88B | $705.1M |
| FY2018 | $593.2M | $3.40B | $669.2M |
| FY2019 | $1.13B | $3.91B | $738.4M |
| FY2020 | $1.22B | $4.62B | $738.7M |